Indatuximab ravtansine Antibody
Indatuximab ravtansine (BT-062) is a CD138-targeting antibody-drug conjugate (ADC) composed of a chimeric anti-CD138 antibody linked to the cytotoxic maytansinoid DM4. It has demonstrated antitumor activity in preclinical models of multiple myeloma, supporting its investigation in both in vitro and in vivo research applications.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Antibacterial
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog